An ‘Omics Revolution: What’s Next for High-Flying ‘ARKG’

Investors looking for disruptive growth in the healthcare sector need not look beyond the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG). ARKG’s stellar track record is rooted in ARK Investment Management’s ability to put together a portfolio that is reflective of the myriad...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.